The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection

Sanjeeth Rajaram(Cincinnati Children's Hospital Medical Center), Stephen N. Waggoner(Cincinnati Children's Hospital Medical Center), Laura M. Canaday(Cincinnati Children's Hospital Medical Center), William J. Zacharias(Cincinnati Children's Hospital Medical Center), Seth D. Reighard(University of Cincinnati Medical Center), Ayad Ali(Cincinnati Children's Hospital Medical Center), Ivayla E. Gyurova(Cincinnati Children's Hospital Medical Center), Matthew T. Weirauch(Cincinnati Children's Hospital Medical Center), Jonathan S. Fletcher(University of Cincinnati Medical Center), Michael T. Borchers(Cincinnati VA Medical Center), Andrew Cox(Cincinnati Children's Hospital Medical Center), David E. Ochayon(Cincinnati Children's Hospital Medical Center), Hitesh Deshmukh(Cincinnati Children's Hospital Medical Center), Kelly M. Rangel(Cincinnati Children's Hospital Medical Center), Leah C. Kottyan(Cincinnati Children's Hospital Medical Center)
Immunity
May 13, 2020
10.1016/j.immuni.2020.04.018
Cited by 26

Related Papers

Determination and Inference of Eukaryotic Transcription Factor Sequence Specificity
|Cell|2014|2k
Natural killer cells act as rheostats modulating antiviral T cells
|Nature|2011|613
Transancestral mapping and genetic load in systemic lupus erythematosus
|Nature Communications|2017|436
The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future
|Cell stem cell|2020|419
Paternally Inherited DLK1 Deletion Associated With Familial Central Precocious Puberty
|The Journal of Clinical Endocrinology & Metabolism|2017|216